Latest News & Features
Americas
Arent Fox has hired Jay Deshmukh as a partner in the firm's New York office, where he will focus on patent litigation and counselling, particularly for the generic pharmaceutical industry. 16 December 2016
Medtech
Roche has terminated its commercialisation and licensing agreement with Pacific Biosciences for the development and supply of diagnostic products. 16 December 2016
article
At the Life Sciences Patents Network Europe 2016, a conference hosted in London last week by LSIPR, Ednaldo Silva of RoyaltyStat discusses IP licensing in the life sciences industry. 16 December 2016
Americas
Idenix Pharmaceuticals, a subsidiary of Merck, has been awarded $2.5 billion in a patent battle against Gilead over Gilead's drugs Sovaldi and Harvoni, treatments for hepatitis C. 16 December 2016
article
Hearing aid companies that did not convert to 3D printing pills “simply went bust”, says Stella Wong in a video interview with LSIPR at its conference, Life Sciences Patents Network Europe, held in London last week. 15 December 2016
article
In a video interview at Life Sciences Patents Network Europe 2016, a conference hosted in London last week by LSIPR, Marjan Noor of Allen & Overy discusses developments around second medical use patents. 15 December 2016
article
Heli Pihlajamaa, director of patent law at the European Patent Office, gives her advice for plant patent owners last week at the Life Sciences Patents Network Europe, a conference hosted by LSIPR in London. 15 December 2016
Americas
Biopharmaceutical company UCB Biopharma has filed a complaint against biotech developer MedImmune for alleged patent infringement. 15 December 2016
article
The US International Trade Commission has agreed to start an investigation into certain single-molecule nucleic acid sequencing systems and reagents, consumables, and software. 15 December 2016
Biotechnology
Denmark-based ExpreS2ion Biotechnology and Abivax, a French biotechnology company, have entered into a service and commercial licensing agreement under which the companies will collaborate in their development of a treatment for Ebola. 15 December 2016